KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cvs Health (CVS) Debt to Equity (2016 - 2025)

Cvs Health (CVS) has disclosed Debt to Equity for 17 consecutive years, with $0.8 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity fell 5.25% year-over-year to $0.8, compared with a TTM value of $0.8 through Dec 2025, down 5.25%, and an annual FY2025 reading of $0.8, down 5.25% over the prior year.
  • Debt to Equity was $0.8 for Q4 2025 at Cvs Health, down from $0.84 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.87 in Q1 2021 and bottomed at $0.72 in Q2 2022.
  • Average Debt to Equity over 5 years is $0.8, with a median of $0.81 recorded in 2023.
  • The sharpest move saw Debt to Equity decreased 23.05% in 2021, then grew 18.9% in 2023.
  • Year by year, Debt to Equity stood at $0.75 in 2021, then decreased by 3.0% to $0.73 in 2022, then rose by 10.06% to $0.8 in 2023, then increased by 5.71% to $0.85 in 2024, then dropped by 5.25% to $0.8 in 2025.
  • Business Quant data shows Debt to Equity for CVS at $0.8 in Q4 2025, $0.84 in Q3 2025, and $0.82 in Q2 2025.